French Pharmaceuticals & Biotech Big Green Snowflakes

Sanofi

Market Cap: €90.4b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Vetoquinol

Market Cap: €829.8m

A veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.

Boiron

Market Cap: €460.1m

Manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally.

Virbac

Market Cap: €2.8b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.

Eurofins Scientific

Market Cap: €12.1b

Provides various analytical testing and laboratory services worldwide.

DBV Technologies

Market Cap: €722.0m

A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.

Cellectis

Market Cap: €193.4m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.

ABIONYX Pharma

Market Cap: €70.9m

A biotech company, discovers and develops therapies for the treatment of renal, metabolic, and ophthalmic diseases in France and the United States.

MedinCell

Market Cap: €889.2m

Engages in the research and development of biodegradable polymer-based processes for the controlled and prolonged delivery of active pharmaceutical ingredients into the human body and animals in France.

Genfit

Market Cap: €656.3m

Engages in the research and development of medicines and diagnostic solutions in France and internationally.

MaaT Pharma

Market Cap: €54.6m

A late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival.

Eurobio Scientific Société anonyme

Market Cap: €209.4m

Engages in research, development, and marketing specialty diagnostic products in the areas of transplantation, infectious diseases, autoimmunity, oncology, and life sciences.

Oncodesign Société Anonyme

Market Cap: €99.4m

Oncodesign Société Anonyme, a biopharmaceutical company, conducts research and development work on new therapeutic and diagnostic tools with pharmaceutical firms, biotech companies, public research institutions, and investment groups.

Novacyt

Market Cap: €39.9m

Develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors.

Sartorius Stedim Biotech

Market Cap: €17.5b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

Ipsen

Market Cap: €12.7b

A biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience in North America, Europe, and internationally.

Valbiotis

Market Cap: €19.4m

Engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France and Asia.

ABIVAX Société Anonyme

Market Cap: €9.4b

A clinical-stage biotechnology company, develops therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.

OSE Immunotherapeutics

Market Cap: €78.8m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

GenSight Biologics

Market Cap: €19.9m

A clinical-stage biotechnology company, discovers, develops, and commercializes novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.

Adocia

Market Cap: €80.3m

A clinical-stage biotechnology company, researches and develops therapeutic solutions for diabetes and obesity.

Aelis Farma

Market Cap: €13.9m

A clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.

THX Pharma Société Anonyme

Market Cap: €60.4m

A biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders.

Nicox

Market Cap: €34.3m

Operates as an ophthalmology company in France and internationally.

Eurofins-Cerep

Market Cap: €82.2m

Provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally.

Sensorion

Market Cap: €145.9m

A biotechnology company, engages in the development of novel therapies to restore, treat, and prevent hearing loss disorders in France.

Oncodesign Precision Medicine Société anonyme

Market Cap: €6.2m

A biopharmaceutical company, engages in the precision medicine business.

Neovacs

Market Cap: €127.3k

A biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France.

Euroapi

Market Cap: €95.1m

Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally.

Innate Pharma

Market Cap: €203.8m

Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.

Plant Advanced Technologies

Market Cap: €5.0m

A plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France.

Nanobiotix

Market Cap: €1.8b

Operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs.

Valneva

Market Cap: €466.5m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Pherecydes Pharma Société anonyme

Market Cap: €14.4m

Pherecydes Pharma Société anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages.

Transgene

Market Cap: €196.4m

A biotechnology company, designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer in France.

genOway Société anonyme

Market Cap: €23.2m

A biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide.